Polymorphisms of the tumour necrosis factor α gene at position - 308 and TNFd microsatellite in primary IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 18, Issue 4, 2003, Pages 724-731

  Tuglular, Serhan ^a,b   Berthoux, Patricia ^a   Berthoux, François ^a  

^a University North Hospital   (France)

^b Division of Nephrology   (Turkey)

Author keywords

Gene polymorphism; Genotype phenotype correlation; IgA nephropathy; Promoter region ( 308); TNFd microsatellites; Tumour necrosis factor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE FUNCTION; GENE STRUCTURE; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLOMERULITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KAPLAN MEIER METHOD; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SURVIVAL;

ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037384094     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg010     Document Type: Article

References (24)

1. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-215
2. Ruddle NH. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opin Immunol 1992; 4: 327-332
3. Arima S, Nakayama M, Naito M, Sato T, Takahashi K. Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 1991; 39: 684-692
4. Yoshioka K, Takemura T, Murakami K et al. In situ expression of cytokines in IgA nephritis. Kidney Int 1993; 44: 825-833
5. Lim CS, Zheng S, Kim YS et al. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 2001; 16: 269-275
6. Matsumoto K. Increased release of tumor necrosis factor-alpha by monocytes from patients with glomerulonephritis. Clin Nephrol 1993; 40: 148-154
7. Kim MJ, Park JK, Ahn JH, Ihm CG, Lee TW. Expression of intercellular adhesion molecule-1 on mouse mesangial cells and cytokines from mononuclear cells of IgA nephropathy. Contrib Nephrol 1995; 111: 135-143
8. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron 1996; 74: 79-88
9. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA, A1, B8 and DR3 alleles. J Exp Med 1993; 177: 557-560
10. Wilson AG, Symons JA, Mcdowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199
11. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-186
12. Asano H, Kobayashi T, Uchida K et al. Significance of tumor necrosis factor microsatellite polymorphism in renal transplantation. Tissue Antigens 1997; 50: 484-488
13. Alamartine E, Sabatier JC, Guérin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analysis. Am J Kidney Dis 1991; 18: 12-19
14. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-789
15. Lee EY, Yang DH, Hwang KY, Hong SY. Is tumor necrosis factor genotype (TNFA2/TNFA2) a genetic prognostic factor of an unfavorable outcome in IgA nephropathy? J Korean Med Sci 2001; 16: 751-755
16. Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int 2002; 61: 1079-1085
17. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406
18. Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995; 45: 1-12
19. Sahoo S, Kang S, Supran S, Saloman R, Wolfe H, Freeman RB. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation. Transplantation 2000; 69: 880-884
20. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941-3946
21. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449
22. Rink L, Kirchner H. Recent progress in the tumor necrosis factor-alpha field. Int Arch Allergy Immunol 1996; 111: 199-209
23. Ortiz A, Bustos C, Alonso J et al. Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. Adv Nephrol Necker Hosp 1995; 24: 53-77
24. Gharavi AG, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q 22-23. Nature Gen 2000; 26: 354-357